Favorable News Coverage Somewhat Unlikely to Affect Waters (WAT) Share Price

News stories about Waters (NYSE:WAT) have trended positive on Wednesday, according to Accern Sentiment. The research firm ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Waters earned a coverage optimism score of 0.25 on Accern’s scale. Accern also assigned news coverage about the medical instruments supplier an impact score of 46.3833425540159 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:

Waters (NYSE WAT) traded up $0.94 during trading hours on Wednesday, reaching $195.20. 456,734 shares of the company were exchanged, compared to its average volume of 515,042. Waters has a 1-year low of $133.71 and a 1-year high of $201.95. The company has a market capitalization of $15,482.69, a price-to-earnings ratio of 27.04, a price-to-earnings-growth ratio of 2.82 and a beta of 0.82. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66.

Waters (NYSE:WAT) last released its quarterly earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.03. Waters had a net margin of 24.34% and a return on equity of 23.61%. The business had revenue of $565.58 million for the quarter, compared to analyst estimates of $555.25 million. During the same period last year, the firm earned $1.57 earnings per share. Waters’s revenue for the quarter was up 7.4% compared to the same quarter last year. analysts anticipate that Waters will post 7.42 EPS for the current fiscal year.

Several equities analysts have recently weighed in on WAT shares. Barclays increased their price objective on shares of Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 25th. Deutsche Bank increased their price objective on shares of Waters from $199.00 to $200.00 and gave the company a “hold” rating in a research report on Wednesday, October 25th. Citigroup reissued a “neutral” rating and issued a $180.00 price objective on shares of Waters in a research report on Wednesday, October 25th. Robert W. Baird increased their price objective on shares of Waters from $196.00 to $199.00 and gave the company an “outperform” rating in a research report on Wednesday, October 25th. Finally, Jefferies Group reissued a “hold” rating and issued a $175.00 price objective on shares of Waters in a research report on Thursday, August 31st. One investment analyst has rated the stock with a sell rating, ten have given a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $193.62.

In related news, Director William J. Miller sold 3,500 shares of the firm’s stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $194.94, for a total transaction of $682,290.00. Following the transaction, the director now directly owns 25,849 shares of the company’s stock, valued at $5,039,004.06. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Elizabeth B. Rae sold 12,000 shares of the firm’s stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the transaction, the senior vice president now directly owns 18,129 shares in the company, valued at $3,588,635.55. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 64,313 shares of company stock worth $12,503,037. 5.07% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: This news story was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.dispatchtribunal.com/2017/12/06/favorable-news-coverage-somewhat-unlikely-to-affect-waters-wat-share-price.html.

Waters Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply